Literature DB >> 29759770

Ibrutinib, an Approved Tyrosine Kinase Inhibitor as a Potential Cause of Recurrent Polymorphic Ventricular Tachycardia.

János Tomcsányi1, Zoltán Nényei2, Zoltán Mátrai3, Béla Bózsik2.   

Abstract

Entities:  

Keywords:  ibrutinib; polymorphic ventricular tachycardia; proarrhythmia; tyrosine kinase inhibitor

Mesh：

Substances：

Year:  2016        PMID： 29759770     DOI： 10.1016/j.jacep.2016.07.004

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN： 2405-500X


× No keyword cloud information.
  7 in total

1.  Ventricular arrhythmias and sudden death in patients taking ibrutinib.

Authors:  Benjamin L Lampson; Lijian Yu; Robert J Glynn; Jacqueline C Barrientos; Eric D Jacobsen; Versha Banerji; Jeffrey A Jones; Renata Walewska; Kerry J Savage; Gregory F Michaud; Javid J Moslehi; Jennifer R Brown
Journal:  Blood       Date:  2017-02-21       Impact factor: 22.113

Review 2.  Targeting BTK in CLL: Beyond Ibrutinib.

Authors:  David A Bond; Jennifer A Woyach
Journal:  Curr Hematol Malig Rep       Date:  2019-06       Impact factor: 3.952

Review 3.  Ibrutinib in the Treatment of Solid Tumors: Current State of Knowledge and Future Directions.

Authors:  Katarzyna Szklener; Adam Michalski; Klaudia Żak; Michał Piwoński; Sławomir Mańdziuk
Journal:  Cells       Date:  2022-04-14       Impact factor: 7.666

4.  Acute Effects of Ibrutinib on Ventricular Arrhythmia in Spontaneously Hypertensive Rats.

Authors:  Beibei Du; Praloy Chakraborty; Mohammed Ali Azam; Stéphane Massé; Patrick F H Lai; Ahmed Niri; Daoyuan Si; Paaladinesh Thavendiranathan; Husam Abdel-Qadir; Filio Billia; Kumaraswamy Nanthakumar
Journal:  JACC CardioOncol       Date:  2020-11-17

Review 5.  Ibrutinib-Associated Cardiotoxicity: From the Pharmaceutical to the Clinical.

Authors:  Rong Dong; Youyou Yan; Xiaokang Zeng; Nengming Lin; Biqin Tan
Journal:  Drug Des Devel Ther       Date:  2022-09-20       Impact factor: 4.319

Review 6.  Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia.

Authors:  Joerg Herrmann
Journal:  Nat Rev Cardiol       Date:  2020-03-30       Impact factor: 32.419

Review 7.  PI3Kα in cardioprotection: Cytoskeleton, late Na+ current, and mechanism of arrhythmias.

Authors:  Pavel Zhabyeyev; Xueyi Chen; Bart Vanhaesebroeck; Gavin Y Oudit
Journal:  Channels (Austin)       Date:  2019-12       Impact factor: 2.581
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.